FindTrial
Sign In

The regulatory mechanism of HSF4 signaling pathway in liver cancer

The regulatory mechanism of HSF4 signaling pathway in liver cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025641
Enrollment
Unknown
Registered
2019-09-03
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Case series:N/A

Sponsors

The Fourth Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: The patients was initially diagnosed with hepatocellular carcinoma and pathologically diagnosed with hepatocellular carcinoma.

Exclusion criteria

Exclusion criteria: Undergo chemotherapy and radiation therapy.

Design outcomes

Primary

MeasureTime frame
Hsf4 expression quantity;Overall survival;—

Countries

China

Contacts

Public ContactZhu Xiangnan

The Fourth Affiliated Hospital of Nanchang University

87224255@qq.com+86 13807918420

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026